BSY001

BSY001 · China National Biotec Group Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BSY001, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. [Phase 1]